Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|November 6, 2020
The adjuvant use of capecitabine for residual disease following pre-operative chemotherapy for breast cancer: Challenges applying CREATE-X to a US populationKassidy Beyerlin, Rachel Jimenez, Mark Zangardi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 8, 2016
Intratumor Heterogeneity of Homologous Recombination Deficiency in Primary Breast CancerMarie-Kristin von Wahlde, Kirsten M Timms, Anees Chagpar, et al.
Oncotarget|March 17, 2016
Mutation based treatment recommendations from next generation sequencing data: a comparison of web toolsJaymin M Patel, Joshua Knopf, Eric Reiner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2016
Immune Signatures Following Single Dose Trastuzumab Predict Pathologic Response to PreoperativeTrastuzumab and Chemotherapy in HER2-Positive Early Breast CancerVinay Varadan, Hannah Gilmore, Kristy L S Miskimen, et al.
International Journal of Cancer|August 19, 2015
Brief-exposure to preoperative bevacizumab reveals a TGF-β signature predictive of response in HER2-negative breast cancersVinay Varadan, Sitharthan Kamalakaran, Hannah Gilmore, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 19, 2024
PEARL: A Phase Ib/II Biomarker Study of Adding Radiation Therapy to Pembrolizumab Before Neoadjuvant Chemotherapy in Human Epidermal Growth Factor Receptor 2-Negative Breast CancerAlice Y Ho, Stephen Shiao, Samantha A Kobald, et al.
Annals of Surgery|May 19, 2016
Economic Impact of Routine Cavity Margins Versus Standard Partial Mastectomy in Breast Cancer Patients: Results of a Randomized Controlled TrialAnees B Chagpar, Nina R Horowitz, Brigid K Killelea, et al.
NPJ Precision Oncology|September 22, 2021
Systematic tissue collection during clinical breast biopsy is feasible, safe and enables high-content translational analysesSiang-Boon Koh, Brian N Dontchos, Veerle Bossuyt, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 27, 2023
Peripheral blood TCR clonotype diversity as an age-associated marker of breast cancer progressionJun Nishida, Simona Cristea, Sudheshna Bodapati, et al.
Histopathology|March 5, 2024
A dedicated structured data set for reporting of invasive carcinoma of the breast in the setting of neoadjuvant therapy: recommendations from the International Collaboration on Cancer Reporting (ICCR)Veerle Bossuyt, Elena Provenzano, W Fraser Symmans, et al.
Pageof 5